Suppr超能文献

膜联蛋白介导的人中性粒细胞质膜与磷脂囊泡的膜融合。

Annexin-mediated membrane fusion of human neutrophil plasma membranes and phospholipid vesicles.

作者信息

Oshry L, Meers P, Mealy T, Tauber A I

机构信息

William B Castle Hematology Laboratory, Boston City Hospital, Department of Medicine, Boston University School of Medicine, MA 02118.

出版信息

Biochim Biophys Acta. 1991 Jul 22;1066(2):239-44. doi: 10.1016/0005-2736(91)90192-b.

Abstract

Membrane fusion was studied using human neutrophil plasma membrane preparations and phospholipid vesicles approximately 0.15 microns in diameter and composed of phosphatidylserine and phosphatidylethanolamine in a ratio of 1 to 3. Liposomes were labeled with N-(7-nitrobenzo-2-oxa-1,3-diazol-4-yl (NBD) and lissamine rhodamine B derivatives of phospholipids. Apparent fusion was detected as an increase in fluorescence of the resonance energy transfer donor, NBD, after dilution of the probes into unlabeled membranes. 0.5 mM Ca2+ alone was sufficient to cause substantial fusion of liposomes with a plasma membrane preparation but not with other liposomes. Both annexin I and des(1-9)annexin I caused a substantial increase in the rate of fusion under these conditions while annexin V inhibited fusion. Fusion mediated by des(1-9)annexin I was observed at Ca2+ concentrations as low as approximately 5 microM, suggesting that the truncated form of this protein may be active at physiologically low Ca2+ concentrations. Trypsin treated plasma membranes were incapable of fusion with liposomes, suggesting that plasma membrane proteins may mediate fusion. Liposomes did not fuse with whole cells at any Ca2+ concentration, indicating that the cytoplasmic side of the membrane is involved. These results suggest that annexin I and unidentified plasma membrane proteins may play a role in Ca(2+)-dependent degranulation of human neutrophils.

摘要

使用人中性粒细胞质膜制剂和直径约0.15微米、由磷脂酰丝氨酸和磷脂酰乙醇胺按1比3比例组成的磷脂囊泡研究膜融合。脂质体用N-(7-硝基苯并-2-恶唑-1,3-二氮杂环丁二烯-4-基)(NBD)和磷脂的丽丝胺罗丹明B衍生物标记。在将探针稀释到未标记的膜中后,共振能量转移供体NBD的荧光增加被检测为明显的融合。单独的0.5 mM Ca2+足以导致脂质体与质膜制剂大量融合,但与其他脂质体不融合。在这些条件下,膜联蛋白I和去(1-9)膜联蛋白I均导致融合速率大幅增加,而膜联蛋白V抑制融合。在低至约5 microM的Ca2+浓度下观察到去(1-9)膜联蛋白I介导的融合,这表明该蛋白的截短形式可能在生理低Ca2+浓度下具有活性。经胰蛋白酶处理的质膜无法与脂质体融合,这表明质膜蛋白可能介导融合。在任何Ca2+浓度下脂质体均不与完整细胞融合,这表明膜的细胞质侧参与其中。这些结果表明,膜联蛋白I和未鉴定的质膜蛋白可能在人中性粒细胞的Ca(2+)依赖性脱颗粒中发挥作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验